• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of studies on alcohol and drugs. >Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change
【24h】

Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change

机译：通过系统变化促进采用阿片类药物和酒精使用障碍的药物

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: The Medication Research Partnership (MRP), a collaboration between a national commercial health plan and nine addiction treatment centers, implemented organizational and system changes to promote use of federally approved medications for treatment of alcohol and opioid use disorders. Method: A difference-in-differences analysis examined change over time in the percentage of patients receiving a prescription medication for alcohol or opioid use disorders treated in MRP (n = 9) and comparison (n = 15) sites. Results: MRP clinics experienced a 2.4-fold increase in patients receiving an alcohol or opioid prescription (13.2% at baseline to 31.7% at 3 years after MRP initiation); comparison clinics experienced significantly less change (17.6% to 23.5%) with an adjusted difference-in-differences of 12.5% (95% CI [5.4, 19.6],p = .001). MRP sites increased the patients with prescriptions to treat opioid use disorder from 17.0% (baseline) to 36.8% (3 years after initiation), with smaller changes observed in comparison sites (23.2% to 24.0%) and a 3-year post-initiation adjusted difference-in-differences of 19% (95% CI [8.5, 29.5], p = .000). Medications for alcohol use disorders increased in both MRP (9.0% to 26.5%) and comparison sites (11.4% to 23.1%). Conclusions: Promoting the use of medications to support recovery required complex interventions. The Advancing Recovery System Change Model, initially developed in publicly funded systems of care, was successfully adapted for commercial sector use. The model provides a framework for providers and commercial health plans to collaborate and increase patient access to medications.
机译：目的：药物研究伙伴关系（MRP）是国家商业卫生计划和九个成瘾治疗中心的合作，实施组织和系统的变化，以促进使用联邦批准的药物治疗酒精和阿片类药物使用障碍。方法：在接受在MRP（n = 9）和比较（n = 15）位的比较（n = 15）位的患者的患者的患者的患者百分比中，检查差异随时间的变化。结果：MRP诊所在接受酒精或阿片类药物处方的患者增加了2.4倍的增加（在MRP启动后3年在基线下为31.7％）;比较诊所的变化显着降低（17.6％至23.5％），调整后差异为12.5％（95％CI [5.4,19.6]，P = .001）。 MRP遗址增加了以17.0％（基线）治疗阿片类药物的患者（基线）至36.8％（开始后3年），在比较点观察到较小的变化（23.2％至24.0％）和3年后发芽后3年调整后差异为19％（95％CI [8.5,29.5]，P = .000）。醇类使用障碍的药物在MRP（9.0％至26.5％）和比较点（11.4％至23.1％）中增加。结论：促进使用药物以支持恢复所需的复杂干预措施。推进的回收系统变更模型最初在公开资助的护理系统中开发，成功适用于商业部门使用。该模型为提供商和商业健康计划提供了一个框架，以协作和增加患者对药物的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号